Daily non-political popular news in brief.

Sensitivity to diverse range of chemotherapeutic drugs linked to common pathway

Using a functional genomic screen, scientists have defined elements that impact the responsiveness of cancer cells to drugs commonly used as anticancer therapeutics. The research, published in the June issue of the journal Cancer Cell, published by Cell Press, identifies individual genes that are associated with resistance to chemotherapeutic drugs, and sets the stage for future studies that may significantly enhance the ability to predict whether or not a particular tumor will respond to treatment.

Read more »

Keywords: sensitivity, diverse, range, chemotherapeutic, drugs, linked, pathway, drug

« Previous | Next »

Similar news on "Sensitivity to diverse range of chemotherapeutic drugs linked to common pathway":

1. Cell skeleton may hold key to overcoming drug resistance in cancer
   10-03-2007 · EurekAlert!
   Researchers have uncovered a new way in which a cell protein protects cancer cellsfrom a wide range of chemotherapeutic drugs, identifying a possible target forimproving treatment outcomes for patients.
   Similar news · Read more »
   
2. Hope for a more effective and less toxic cancer drug
   11-14-2006 · EurekAlert!
   Detailed evaluation conducted at WEHI into a possible new cancer drug suggests that it may prove to be more effective and less toxic than current chemotherapeutic drugs.
   Similar news · Read more »
   
3. Medication costs infrequently addressed when newly prescribed, UCLA study finds
   11-08-2006 · EurekAlert!
   A new UCLA study has found that physicians discuss cost and aspects of obtaining newly prescribed medications only about one-third of the time during patient/doctor interactions.But questions about pricing and prescription drug insurance coverage are critical -- the high costs of drugs, including out-of-pocket payouts such as co-payments, are linked to patient non-adherence in maintaining their dosage schedules
   Similar news · Read more »
   
4. Scientists decode genomes of diverse TB isolates
   11-20-2007 · EurekAlert!
   Collaboration led by US and South Africa researchers announced the first genome sequence of an extensively drug-resistant strain of Mycobacterium tuberculosis linked to more than 50 deaths in a recent TB outbreak in KwaZulu-Natal, South Africa. Initial comparisons of the genome sequences reveal that drug-resistant and drug-sensitive microbes differ at only a few dozen locations along the 4-million-letter DNA code.
   Similar news · Read more »
   
5. New test predicts blood cancer's sensitivity to experimental cancer drug
   01-22-2007 · EurekAlert!
   A test developed by Dana-Farber Cancer Institute scientists is the first to identify which malignant blood cells are highly vulnerable to a promising type of experimental drugs that unleash pent-up "cell suicide" factors to destroy the cancer.
   Similar news · Read more »
   
6. Modeling lung cancer
   02-12-2007 · EurekAlert!
   In a new report in the February 15 issue of G&D, Dr. Martin McMahon and colleagues present a novel mouse model of non-small cell lung cancer, which will serve as a useful tool to test the efficacy of novel chemotherapeutic drug therapies in the early stages of lung tumorigenesis. Their paper provides evidence to support the use of a relatively new class of drugs, called MEK inhibitors, for lung cancer patients whose tumors contain mutations in the BRaf gene.
   Similar news · Read more »
   
7. Drug linked to increase in brain hemorrhage cases
   01-08-2007 · EurekAlert!
   The rate of brain hemorrhages associated with blood thinning drugs quintupled during the 1990s, according to a study published in the January 9, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology. In people over age 80, the rate increased more than tenfold.
   Similar news · Read more »
   
8. Genetics of imatinib resistance in acute lymphoblastic leukemia
   08-29-2007 · EurekAlert!
   In the Sept. 15 issue of Genes & Development, scientists lend new insights into how an aggressive form of acute lymphoblastic leukemia develops, and how sensitivity to the targeted chemotherapeutic drug, imatinib, can be diminished through interactions between tumor cells and the host microenvironment.
   Similar news · Read more »
   
9. MIT model could predict cells' response to drugs
   07-30-2007 · EurekAlert!
   MIT researchers have developed a model that could predict how cells will respond to targeted drug therapies. Models based on this approach could help doctors make better treatment choices and drug developers identify the ideal compound. In addition, the model could help test the effectiveness of drugs for a wide range of diseases, including cancer, arthirtis, and immune system disorders.
   Similar news · Read more »
   
10. MU researchers studying model to learn why certain cancers become resistant to drugs
    10-02-2007 · EurekAlert!
    MU researchers are studying a model organism called "Dictyostelium discoideum" to better understand mechanisms of cisplatin drug sensitivity.
    Similar news · Read more »